RESEARCH TRIANGLE PARK, NC, April 10, 2023 (GLOBE NEWSWIRE) — Science 37 Holdings, Inc. SNCE, the industry-leading Metasite™, today announced the award of inducement equity awards under Science 37 Holdings, Inc.’s 2022 Employment Inducement Incentive Award Plan (the “Plan”). The plan was approved by Science 37’s board of directors in November 2022. In accordance with NASDAQ Listing Rule 5635(c)(4), the awards were approved by Science 37’s Compensation Committee and were granted as a significant incentive to the non-executive employees. Entry into an employment relationship with the company.

In connection with the commencement of employment on April 10, 2023, options to purchase an aggregate of 110,800 common shares of Science 37 at an exercise price of $0.29 per share, equal to the closing price of Science 37 common stock on Nasdaq Stock Market LLC on On the grant date, 3 new employees were granted.

The options have a term of 10 years and a four-year vesting schedule, with 25% of the option shares vesting on the first anniversary of the grant date and the remaining underlying shares vesting in equal monthly installments until full vesting on the fourth anniversary of the grant date, subject to the continued employment of the relevant employee at Science 37 until the respective exercise date.

About science 37
Science37 Holdings, Inc SNCE Mission is to accelerate clinical research by providing patients with universal access to studies. Through our Metasite™, we are reaching an expanded population beyond the traditional website and achieving our goal of clinical research that works for everyone – with greater patient diversity. Patients are given the flexibility to attend from the comfort of their own home, at their local healthcare provider, or at a traditional location if needed. Our metasite is built on a proprietary technology platform with in-house medical and operational experts driving unified study coordination and better compliance and…